Cogent Biosciences
COGT
#6495
Rank
โ‚ฌ0.49 B
Marketcap
4,35ย โ‚ฌ
Share price
-10.51%
Change (1 day)
-31.66%
Change (1 year)

Cogent Biosciences (COGT) - Cash on Hand

Cash on Hand as of December 2024 : โ‚ฌ0.26 Billion

According to Cogent Biosciences's latest financial reports the company has โ‚ฌ0.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cogent Biosciences - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.27 B14.77%
2023-12-31โ‚ฌ0.24 B-0.56%
2022-12-31โ‚ฌ0.24 B24.61%
2021-12-31โ‚ฌ0.19 B-1.48%
2020-12-31โ‚ฌ0.19 B489.4%
2019-12-31โ‚ฌ33.4 M-51.37%
2018-12-31โ‚ฌ68.7 M101.24%
2017-12-31โ‚ฌ34.13 M-47.59%
2016-12-31โ‚ฌ65.13 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ14.95 M-94.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.39 B 50.46%๐Ÿ‡บ๐Ÿ‡ธ USA